ReShape Lifesciences Inc reports results for the quarter ended in March - Earnings Summary

Vyome Holdings

23/05/2022 14:32

* ReShape Lifesciences Inc  RSLS.OQ  reported a quarterly
adjusted
loss of 44 cents​​ per share for the quarter ended in March. The
mean expectation of two analysts for the quarter was for a loss
of 34 cents per share.
    * Revenue was $2.44 million​;  analysts expected $3.22
million. 
    * ReShape Lifesciences Inc's reported EPS for the quarter
was a
loss of 44 cents​.
    * The mean earnings estimate of analysts had fallen by
about 86.5%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * ReShape Lifesciences Inc shares had fallen by 30.8% this
quarter and lost 50.2% so far this year.
    * The company reported a quarterly loss of $8.22 million.
    * Wall Street's median 12-month price target for ReShape
Lifesciences Inc is $4.75 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 23 at 01:31 p.m.  ​All
figures in US dollars unless otherwise stated